Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Nov 20, 2017

30071_dirs_2017-11-20_0487a2e7-4d65-4b5a-93ba-edd895dda161.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-16

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-16 ResMed Common Stock A 2991 Acquired 26636 Direct

Footnotes

F1: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2018, or the annual shareholder's meeting in the year following the grant date.